
Source: iQoncept / Shutterstock
Cargo Therapeutics (NASDAQ:CRGX) recently fell short in its earnings report for the final quarter of 2023.
- Recording an earnings per share of -$1.49, the company missed the mark as analysts had predicted an EPS of -$1.44.
- Disappointingly, Cargo Therapeutics did not generate any revenue during the quarter.
This article is from InvestorPlace Media, available at https://investorplace.com/earning-results/2024/03/crgx-stock-earnings-cargo-therapeutics-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC